الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 163 |  |  |
| | | from | 163 | | |
Abstract
Morbid obesity is defined as obesity with a body mass index ≥40, or
≥35 with secondary diseases. Conservative medical therapies in these
individuals generally fail to sustain weight loss. Thus, surgical operations
have evolved, which are based on gastric restriction and/or malabsorption .
Bariatric surgery is currently the most effective treatment to achieve
substantial and long-term weight loss in patients with severe obesity, and it
also has beneficial effects on obesity-associated comorbidities such as type
2 diabetes, cardiovascular disease, and cancer.
LSG is emerging to be one of the most commonly performed bariatric
procedures worldwide. This restrictive procedure has several advantages. It
is technically simpler to perform without the need for an anastomosis. It has
been reported to have a lower morbidity and mortality rate in comparison to
Roux-en-Y gastric bypass or biliopancreatic diversion with or without
duodenal switch. It can be performed concomitantly with other procedures.
IGB has widely been used as a minimally invasive procedure for the
treatment of overweight or obese individuals. It is considered a preferred
method by many due to its safety, tolerability, and relatively low cost,
bridging the gap between conventional methods and bariatric surgery.
Balloon insertion should be considered carefully in patients with large
hiatus hernia, inflammatory bowel disease, and increased risk of upper GI
bleed, drug/alcohol abuse, and uncontrolled psychiatric disease. Several
studies have demonstrated the efficacy and safety of IGBs for temporary
weight reduction with low mortality and morbidity.
The present study aimed to compare early outcomes of the
laparoscopic sleeve gastrectomy with the endoscopic intra-gastric balloon in patients with morbid obesity regarding the degree of weight loss in the first
year, patient’s satisfaction, and complications.
This prospective study involved 60 consecutive patients who
underwent either LSG or IGB insertion. The patients were divided into two
groups: the LSG group, comprising thirty patients who underwent
laparoscopic sleeve gastrectomy, and the IGB group, including thirty
patients who underwent intra-gastric balloon insertion. A short-term followup was conducted for all patients over one year.